Clinical Trial Update: Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation [Phase 4]

View source ↗

Summary

This entry updates a Phase 4 clinical trial evaluating aspirin monotherapy 12 months after drug-eluting stent implantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Yonsei University | Conditions: Drug-eluting Stent (DES) | Phase 4 | Status: UNKNOWN